Quick Overview: Sagar Lonial, Winship Cancer Institute of Emory University, Atlanta, GA, discusses the promising results of anti- Krishna V. Komanduri, MD; David Maloney, MD, PhD; and Stephen J. Schuster, MD, describe the rationale for Speaking from the American Society of Oncology (ASCO) 2018 Annual Meeting, held in Chicago, IL, Stephan Grupp, MD, PhD, ...
Bcma Targeting Car T Lessons - Detailed Overview & Context
Sagar Lonial, Winship Cancer Institute of Emory University, Atlanta, GA, discusses the promising results of anti- Krishna V. Komanduri, MD; David Maloney, MD, PhD; and Stephen J. Schuster, MD, describe the rationale for Speaking from the American Society of Oncology (ASCO) 2018 Annual Meeting, held in Chicago, IL, Stephan Grupp, MD, PhD, ... Hamza Hashmi, MD, Medical University of South Carolina, Charleston, SC, explains where Website: Twitter: Facebook: LinkedIn: ... Ajai Chari, MD; C. Ola Landgren, MD, PhD; Pei Lin, MD; and Nina Shah, MD, describe the potential of B-cell maturation antigen ...
Amrita Krishnan, MD, City of Hope, Duarte, CA, briefly comments on how Alfred Garfall, MD, MS University of Pennsylvania, Pennsylvania, PA, discusses the latest results looking at anti- Laurent Garderet, MD, from Hopital Saint-Antoine, Paris, France, talks to us about exciting new advances in research for the ... A one-time infusion of an investigational Niels van de Donk, MD, PhD, VU University Medical Center, Amsterdam, Netherlands, discusses the downregulation of B-cell ... Carlos Fernandez de Larrea, MD, PhD, University of Barcelona, Barcelona, Spain, outlines a study evaluating whether upfront ...
Deepu Madduri, MD, Icahn School of Medicine at Mount Sinai, New York, NY, discusses the Phase Ib results from the ongoing ... Watch the full course and our most up-to-date content here: Create a free account to track ... Updated Clinical and Correlative Results from the Phase I CRB-402 Study of the Dr. Juan Du (Changzheng Hospital, Naval Medical University—Shanghai, China) provides updates on the study results of ... Tara Gregory, MD, Colorado Blood Cancer Institute, Denver, CO, discusses the results of a Phase I/II trial (NCT03288493) of ... Future relapsed-refractory multiple myeloma treatment strategies with
